AVITA Medical, Inc. Debt Securities, Trading, Unrealized Loss
AVITA Medical, Inc. (RCEL) reported Debt Securities, Trading, Unrealized Loss of $5.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DebtSecuritiesTradingUnrealizedLoss · last filed 2025-02-13
- AVITA Medical, Inc. debt securities, trading, unrealized loss for the quarter ending 2023-12-31 was -$18.00K.
- AVITA Medical, Inc. debt securities, trading, unrealized loss for the quarter ending 2023-09-30 was -$63.00K, a 169.23% decline year-over-year.
- AVITA Medical, Inc. debt securities, trading, unrealized loss for the quarter ending 2023-06-30 was -$107.00K, a 181.06% decline year-over-year.
- AVITA Medical, Inc. debt securities, trading, unrealized loss for the quarter ending 2023-03-31 was $193.00K, a 52.23% decline year-over-year.
- AVITA Medical, Inc. debt securities, trading, unrealized loss for fiscal 2023 was $5.00K, a 98.85% decline from fiscal 2022.
- AVITA Medical, Inc. debt securities, trading, unrealized loss for fiscal 2022 was $434.00K, a 317.31% increase from fiscal 2021.
- AVITA Medical, Inc. debt securities, trading, unrealized loss for fiscal 2021 was $104.00K.
| Period end | Debt Securities, Trading, Unrealized Loss 3 month | Debt Securities, Trading, Unrealized Loss 6 month | Debt Securities, Trading, Unrealized Loss 9 month | Debt Securities, Trading, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$81.00K derived: sum of 2 quarters · filed 2025-02-13 | -$188.00K derived: sum of 3 quarters · filed 2025-02-13 | $5.00K 10-K · filed 2025-02-13 |
| 2023-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$170.00K derived: sum of 2 quarters · filed 2023-11-09 | $23.00K 10-Q · filed 2023-11-09 | -$170.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | -$107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $86.00K 10-Q · filed 2023-08-10 | -$107.00K derived: sum of 3 quarters · filed 2024-02-22 | -$16.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | $193.00K 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $91.00K derived: sum of 3 quarters · filed 2024-02-22 | $223.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | -$193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$102.00K derived: sum of 2 quarters · filed 2024-02-22 | $30.00K derived: sum of 3 quarters · filed 2024-02-22 | $434.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $223.00K derived: sum of 2 quarters · filed 2022-11-10 | $627.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $536.00K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $404.00K 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $104.00K 10-Q · filed 2022-11-10 | $104.00K 10-K · filed 2023-02-23 |